Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Viral Infections During Pregnancy: The Big Challenge Threatening Maternal and Fetal Health. | Matern Fetal Med | 2022 | 35187500 | PubTator, text mining | PubMed |
| A FBXO7/EYA2-SCFFBXW7 axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cells. | Mol Cell | 2022 | 35182481 | PubTator, text mining | PubMed |
| Identification of genomic signatures in bone marrow associated with clinical response of CD19 CAR T-cell therapy. | Sci Rep | 2022 | 35181722 | PubTator, text mining | PubMed |
| Celecoxib Synergistically Enhances MLN4924-Induced Cytotoxicity and EMT Inhibition Via AKT and ERK Pathways in Human Urothelial Carcinoma. | Cell Transplant | 2022 | 35176901 | PubTator, text mining | PubMed |
| Association between the presence of delirium during intensive care unit admission and cognitive impairment or psychiatric problems: the Korean ICU National Data Study. | J Intensive Care | 2022 | 35164863 | PubTator, text mining | PubMed |
| High Glucose Impairs Expression and Activation of MerTK in ARPE-19 Cells. | Int J Mol Sci | 2022 | 35163068 | PubTator, text mining | PubMed |
| Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment. | Cancers (Basel) | 2022 | 35158804 | PubTator, text mining | PubMed |
| Molecular Targets of Triple-Negative Breast Cancer: Where Do We Stand? | Cancers (Basel) | 2022 | 35158750 | PubTator, text mining | PubMed |
| AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis. | Cancers (Basel) | 2022 | 35158733 | PubTator, text mining | PubMed |
| Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. | Mol Cancer | 2022 | 35151318 | PubTator, text mining | PubMed |
| Gas6 induces inflammation and reduces plaque burden but worsens behavior in a sex-dependent manner in the APP/PS1 model of Alzheimer's disease. | J Neuroinflammation | 2022 | 35130912 | PubTator, text mining | PubMed |
| A 10-Gene Signature Identified by Machine Learning for Predicting the Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma. | J Oncol | 2022 | 35111225 | PubTator, text mining | PubMed |
| Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning. | Oncotarget | 2022 | 35106125 | PubTator, text mining | PubMed |
| Lassa virus glycoprotein complex review: insights into its unique fusion machinery. | Biosci Rep | 2022 | 35088070 | PubTator, text mining | PubMed |
| Preclinical Development of ADCT-601, a Novel Pyrrolobenzodiazepine Dimer-based Antibody-drug Conjugate Targeting AXL-expressing Cancers. | Mol Cancer Ther | 2022 | 35086955 | PubTator, text mining | PubMed |
| SCARF1-Induced Efferocytosis Plays an Immunomodulatory Role in Humans, and Autoantibodies Targeting SCARF1 Are Produced in Patients with Systemic Lupus Erythematosus. | J Immunol | 2022 | 35082161 | PubTator, text mining | PubMed |
| [Advances in the Study of Tumor-associated Macrophages in Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2022 | 35078283 | PubTator, text mining | PubMed |
| Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort. | Lung | 2022 | 35066606 | PubTator, text mining | PubMed |
| Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma. | J Biomed Sci | 2022 | 35062934 | PubTator, text mining | PubMed |
| Biological Role of Vitamin K-With Particular Emphasis on Cardiovascular and Renal Aspects. | Nutrients | 2022 | 35057443 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=40